102 related articles for article (PubMed ID: 23102588)
1. Lung transplantation in cystic fibrosis normalizes essential fatty acid profiles.
Witters P; Dupont L; Vermeulen F; Proesmans M; Cassiman D; Wallemacq P; De Boeck K
J Cyst Fibros; 2013 May; 12(3):222-8. PubMed ID: 23102588
[TBL] [Abstract][Full Text] [Related]
2. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.
Strandvik B; Gronowitz E; Enlund F; Martinsson T; Wahlström J
J Pediatr; 2001 Nov; 139(5):650-5. PubMed ID: 11713441
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
Al-Turkmani MR; Freedman SD; Laposata M
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):309-18. PubMed ID: 18036797
[TBL] [Abstract][Full Text] [Related]
4. Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy.
Aldámiz-Echevarría L; Prieto JA; Andrade F; Elorz J; Sojo A; Lage S; Sanjurjo P; Vázquez C; Rodríguez-Soriano J
Pediatr Res; 2009 Nov; 66(5):585-9. PubMed ID: 19851226
[TBL] [Abstract][Full Text] [Related]
5. Influence of lung transplantation on the essential fatty acid profile in cystic fibrosis.
Hanssens L; Duchateau J; Namane SA; Malfroot A; Knoop C; Casimir G
Prostaglandins Leukot Essent Fatty Acids; 2020 Jul; 158():102060. PubMed ID: 32044180
[TBL] [Abstract][Full Text] [Related]
6. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture.
Caramia G; Cocchi M; Gagliardini R; Malavolta M; Mozzon M; Frega NG
Pediatr Med Chir; 2003; 25(1):42-9. PubMed ID: 12920976
[TBL] [Abstract][Full Text] [Related]
7. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
Jumpsen JA; Brown NE; Thomson AB; Paul Man SF; Goh YK; Ma D; Clandinin MT
J Cyst Fibros; 2006 May; 5(2):77-84. PubMed ID: 16507353
[TBL] [Abstract][Full Text] [Related]
8. Association of cystic fibrosis with abnormalities in fatty acid metabolism.
Freedman SD; Blanco PG; Zaman MM; Shea JC; Ollero M; Hopper IK; Weed DA; Gelrud A; Regan MM; Laposata M; Alvarez JG; O'Sullivan BP
N Engl J Med; 2004 Feb; 350(6):560-9. PubMed ID: 14762183
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide.
Guilbault C; Wojewodka G; Saeed Z; Hajduch M; Matouk E; De Sanctis JB; Radzioch D
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):100-6. PubMed ID: 19059886
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
[TBL] [Abstract][Full Text] [Related]
11. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients.
Van Biervliet S; Vanbillemont G; Van Biervliet JP; Declercq D; Robberecht E; Christophe A
Ann Nutr Metab; 2007; 51(6):541-9. PubMed ID: 18227622
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid metabolism in cystic fibrosis.
Strandvik B
Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):121-9. PubMed ID: 20673710
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis.
Olveira G; Olveira C; Acosta E; Espíldora F; Garrido-Sánchez L; García-Escobar E; Rojo-Martínez G; Gonzalo M; Soriguer F
Arch Bronconeumol; 2010 Feb; 46(2):70-7. PubMed ID: 20045240
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis and nutrition: linking phospholipids and essential fatty acids with thiol metabolism.
Innis SM; Davidson AG
Annu Rev Nutr; 2008; 28():55-72. PubMed ID: 18498235
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation.
Krenn K; Klepetko W; Taghavi S; Paulus P; Aharinejad S
Eur J Cardiothorac Surg; 2007 Jul; 32(1):35-41. PubMed ID: 17481912
[TBL] [Abstract][Full Text] [Related]
16. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation.
Bonvillain RW; Valentine VG; Lombard G; LaPlace S; Dhillon G; Wang G
J Heart Lung Transplant; 2007 Sep; 26(9):890-7. PubMed ID: 17845927
[TBL] [Abstract][Full Text] [Related]
17. Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis.
Coste TC; Deumer G; Reychler G; Lebecque P; Wallemacq P; Leal T
Clin Chem; 2008 Feb; 54(2):388-95. PubMed ID: 18089657
[TBL] [Abstract][Full Text] [Related]
18. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.
Coste TC; Armand M; Lebacq J; Lebecque P; Wallemacq P; Leal T
Clin Biochem; 2007 May; 40(8):511-20. PubMed ID: 17316592
[TBL] [Abstract][Full Text] [Related]
19. Breathing pattern and chest wall volumes during exercise in patients with cystic fibrosis, pulmonary fibrosis and COPD before and after lung transplantation.
Wilkens H; Weingard B; Lo Mauro A; Schena E; Pedotti A; Sybrecht GW; Aliverti A
Thorax; 2010 Sep; 65(9):808-14. PubMed ID: 20805177
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis.
Gronowitz E; Lorentzon M; Ohlsson C; Mellström D; Strandvik B
Br J Nutr; 2008 Jan; 99(1):160-7. PubMed ID: 17697399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
